RETINA-READ-RISK ha compartido esto
In our latest communication, we highlighted the remarkable efforts of E-Seniors, a dedicated team within our consortium, committed to supporting Parisian seniors aged 55 and over. They orchestrated a series of enlightening focus group sessions in Paris, France, where they introduced our innovative device designed to address the risks associated with diabetic retinopathy. These four sessions weren't merely showcases of our state-of-the-art technology. They also served as invaluable forums for discussing the paramount importance of eye health and gathering feedback from our esteemed participants. “At E-Seniors, we're dedicated to empowering individuals aged 55 and over with technology skills for their well-being. Through the Retina Read Risk project, we introduced an innovative tool for detecting a commonly overlooked illness and raised awareness about its risks among our community. The reaction from senior citizens was extremely positive: many stressed the usefulness of this presentation in raising awareness of a disease whose effects they had little prior knowledge of, and of the importance of getting tested. This awareness is crucial in the fight against diabetic retinopathy and in promoting eye health.” Olivier Rappaport, European project manager at E-Seniors We extend our heartfelt gratitude to each participant for their invaluable contributions. For those eager to delve deeper into the intricacies of our project, we invite you to explore the link provided below. https://lnkd.in/eT4j8sxV Furthermore, rest assured that E-Seniors remains steadfast in its commitment to sharing the invaluable insights garnered with our esteemed project partners. Together, we persist in our endeavor to refine this game-changing tool for the betterment of diabetic patients worldwide. Join us on this journey of healthcare innovation and stay tuned for further updates as we continue to make impactful strides in the field. #IISPV #GeneralitatDeCatalunya #InstitutCatalaDeLaSalud #AssociationESeniors #TRCGROUP #Telephonica #FondationDeLavenir #GenesisBiomed #Retinopathy #Diabete #Ophtalmology #Ehealth #IA